You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國醫藥(600056.SH):天方有限獲得他達拉非片藥品註冊證書

格隆匯9月2日丨中國醫藥(600056.SH)公佈,近日,中國醫藥健康產業股份有限公司下屬全資子公司天方藥業有限公司(簡稱“天方有限”)獲得國家藥品監督管理局核准簽發的他達拉非片(簡稱“該藥品”)《藥品註冊證書》。

他達拉非是一種選擇性、可逆性的磷酸二酯酶5(PDE5)抑制劑,用於治療勃起功能障礙。截至公吿披露日,天方有限在該藥品原料藥與片劑項目的累計研發投入約為 1123萬元人民幣(未經審計)。該藥品原料藥已通過國家藥品監督管理局藥品審評中心的技術審評。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account